Gold nanoparticle heat therapy for skin melanoma
Part of Injuries & trauma clinical trials.
This trial tests a new treatment that uses tiny gold particles to heat and destroy melanoma tumors on the skin. It's for people whose melanoma has not responded to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older.
- You have advanced melanoma (stage 3C, 3D, or 4) with tumors on the skin that can be seen and reached.
- Your tumors are 2.5 cm or smaller in size.
- You have already tried at least one standard treatment (like immunotherapy) and it didn't work.
- You are generally in good health (able to care for yourself, life expectancy at least 6 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment combining gold nanoparticles (Au-TMP), radiation therapy, and an immune-boosting drug (anti-PD-1) for advanced melanoma that cannot be surgically removed. The goal is to help your immune system fight the cancer more effectively.
This trial tests whether adding hyperthermia (heating the tumor area) to standard immunotherapy drugs can help control advanced gastrointestinal cancers that have spread to the liver. It may be an option if you have already tried other treatments and are looking for a new approach.
This early-stage study tests whether a targeted radioactive drug can shrink advanced melanoma, either alone or along with nivolumab (an immune-activating medicine). You may be eligible if your melanoma shows a specific target on scan imaging and has progressed despite prior melanoma treatments.
This trial tests whether adding heat therapy (hyperthermia) to radiation therapy works well for older adults with larger non-melanoma skin cancers. It may help shrink tumors without needing surgery.
This Phase 1/2 study tests an “Auger molecular therapy” treatment that uses targeted radiation on certain advanced cancers that have spread to the skin. It may help shrink or control skin tumors where the lesion size and location fit the treatment device.
This study tests a very focused form of radiation for melanoma that has spread and has stopped responding to PD-1 (and sometimes CTLA-4) immunotherapy. It may help by shrinking progressing spots while keeping the immune treatment going.
Hear when a new Cutaneous Metastatic Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.